|
EspAddText
EspRemoveText
|
A new vision for health care in Canada: Addressing the needs of an aging population. 2016 pre-budget submission to the Minister of Finance
|
Parliamentary submission
|
2016
|
|
EspAddText
EspRemoveText
|
Regulatory framework for the mandatory reporting of adverse drug reactions and medical device incidents by provincial and territorial healthcare institutions.
|
Response to consultation
|
2016
|
|
EspAddText
EspRemoveText
|
Consultation on the prescription drug list: Naloxone
|
Response to consultation
|
2016
|
|
EspAddText
EspRemoveText
|
Legalization, regulation and restriction of access to marijuana
|
Response to consultation
|
2016
|
|
EspAddText
EspRemoveText
|
National pharmacare in Canada: Getting there from here
|
Parliamentary submission
|
2016
|
|
EspAddText
EspRemoveText
|
Regulation of Self-Care Products in Canada
|
Response to consultation
|
2016
|
|
EspAddText
EspRemoveText
|
Health Canada’s Consultation on “Plain and Standardized Packaging”
|
Response to consultation
|
2016
|
|
EspAddText
EspRemoveText
|
Statement to the House of Commons Committee on Health addressing the opioid crisis in Canada
|
Parliamentary submission
|
2016
|